Table 7: Summary of Findings on Diabetes Resolution After Adjustable Gastric Banding.
| Study (Year) |
Diabetes Definition |
Follow-up, Months | Patients With Comorbidity at Baseline, N | Resolved, % (n) | Improved, % (n) | No Change, % (n) | Worse, % (n) |
|---|---|---|---|---|---|---|---|
| Dolan (2003) | Decision to stop medication for diabetes was taken to indicate diabetes remission | 6–63 | 49 | 65 (32) | Not reported | Not reported | Not reported |
| Spivak (2003) |
Status based on changes in drug regimen | 6– 27 | 14 | 29 (4) | 36 (5) | 29 (4) | 7 (1) |
| Weiner (2003) |
Required medication for type 2 diabetes | 1–97 | 161 | 92 (148) | Not reported | Not reported | Not reported |
| Zinzindohoue (2003) | Not defined | 1–49.5 (mean, 13) |
29 | 45 (13) | 34 (10) | 17 (5) | 3 (1) |
| Dixon (2001) | Type 2 diabetes, defined by abnormal fasting plasma glucose, HbA1c, fasting insulin, and C-peptide | 12 | 50 | 64 (32) | 26 (13) | 10 (5) | 0 (0) |
(Table reproduced with kind permission from ECRI. Bariatric Surgery for Obesity. 2004. Plymouth Meeting, PA, ECRI. Technology Assessment Report.)